Walgreen Company http://www.alacrastore.com/company-snapshot/Walgreen_Company-1017884 Friday, July 25, 2008 6:21:45 PM 1017884 Walgreen Company en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/spcred/567048spcred/567048normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:58 AM175Summary567048United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 64.3% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates more than 5,461 drugstores (including three mail service facilities, 38 home care facilities, and 18 clinic pharmacies and five specialty pharmacies) in 47 states and Puerto Rico.USA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/556777spcred/556777normThe latest News from S&Pstructuredglobal7/19/2008 2:43:56 AM100News556777United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailNewsNEW YORK (Standard&Poor's) Jan. 11, 2007----Standard&Poor's Ratings Services said today that Deerfield, Ill.-based Walgreen Co.'s (A+/Stable/A-1) announcement Jan. 10, 2007, that its board of directors has authorized a new four-year $1 billion share repurchase program has no immediate impact on the ratings or outlook. Standard&Poor's anticipates Walgreen will fund the share repurchases with its substantial cash flow, thus not affecting credit protection measures. The company generated $1.3 billion of free cash flow in 2006; hence, ratings should not be impacted even if the stock is repurchased in about a year, like with the previous program.USA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGNEWSGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/548747spcred/548747normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:55 AM175Summary548747United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCommercial MBSCorporationsRetailHealth CareSummaryThe ratings on Deerfield, III -based Walgreen Co. reflect the company's leading position in an industry with good business characteristics, and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets, and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 64.3% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates more than 5,461 drugstores (including three mail service facilities, 38 home care facilities, 18 clinic pharmacies, and 5 specialty pharmacies) in 47 states and Puerto Rico.USA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCMBSCORPRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/526974spcred/526974normThe latest Full Report from S&Pglobalstructured7/19/2008 2:43:53 AM400Full Report526974United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailFull ReportHolds the leading position in the high-growth chain drug retail industry; Strong management team; Store-level operating efficiency is the best in the industry; and Long history of growth. Participates in a highly competitive industry. The ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 65.2% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing developmentUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGFULLGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/526976spcred/526976normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:53 AM175Summary526976United StatesDrug RetailUnited StatesStructured FinanceGlobal IssuersCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 65.2% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates more than 5,251 drugstores (including seven mail service facilities, 38 home care facilities, and 16 clinic pharmacies) in 45 states and Puerto Rico. Walgreen has demonstrated unparalleledUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYSTRUCGLOBISSCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/514416spcred/514416normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:51 AM175Summary514416United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest drugstore chain in the industry, based on units. Prescriptions, representing 61.5% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates more than 5,156 drugstores (including seven mail service facilities) in 45 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. Walgreen's store developmentUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/490968spcred/490968normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:50 AM175Summary490968United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on units. Prescriptions, representing 64.5% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates more than 5,068 drugstores (including seven mail service facilities) in 45 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. Walgreen's store developmentUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/479219spcred/479219normThe latest Full Report from S&Pglobalstructured7/19/2008 2:43:46 AM400Full Report479219United StatesDrug RetailUnited StatesStructured FinanceGlobal IssuersCorporationsCommercial MBSRetailHealth CareFull ReportHolds the leading position in the high-growth chain drug retail industry; Strong management team; Store-level operating efficiency is the best in the industry; and Long history of growth. Participates in a highly competitive industry. The ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales. Prescriptions, representing 64% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovativeUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGFULLSTRUCGLOBISSCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/479397spcred/479397normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:46 AM175Summary479397United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales. Prescriptions, representing 64% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of innovative drug products. The company operates almost 5,000 drugstores (including three mail-service facilities) in 45 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to postUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/462570spcred/462570normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:45 AM175Summary462570United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company leads in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 63% of Walgreen's revenues, continue to drive growth and should do so well into the future because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company operates more than 4,805 drugstores in 45 U.S. states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to post double-digit comparable salesUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/445061spcred/445061normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:43 AM175Summary445061United StatesDrug RetailUnited StatesStructured FinanceGlobal IssuersCorporationsCommercial MBSHealth CareRetailSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 61% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company operates more than 4,738 drugstores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to post double-digitUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYSTRUCGLOBISSCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/427609spcred/427609normThe latest Summary from S&Pstructuredglobal7/19/2008 2:43:42 AM175Summary427609United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 65% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company operates more than 4,680 drugstores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to post double-digitUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/413154spcred/413154normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:41 AM175Summary413154United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the second-largest chain drugstore in the industry, based on sales and units. Prescriptions, representing 64% of Walgreen's revenues, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company operates more than 4,582 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to postUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/410701spcred/410701normThe latest Full Report from S&Pglobalstructured7/19/2008 2:43:40 AM400Full Report410701United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailFull ReportHolds the leading position in the high-growth chain drug retail industry; Strong management team; Store-level operating efficiency is the best in the industry; and Long history of growth. Participates in a highly competitive industry. The ratings on Deerfield, Ill.-based Walgreen Co. reflect its leading position in an industry with good business characteristics, and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets, and is the largest chain drugstore in the industry, based on sales and units. Prescriptions--64% of Walgreen's revenue--continue to drive growth and should do so well into the future, because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products.USA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGFULLGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/410711spcred/410711normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:40 AM175Summary410711United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Deerfield, Ill.-based Walgreen Co. reflect its leading position in an industry with good business characteristics, and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets, and is the largest chain drugstore in the industry, based on sales and units. Prescriptions--64% of Walgreen's revenue--continue to drive growth and should do so well into the future, because of an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Walgreen operates more than 4,582 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to post double-digit comparable-sales in its pharmacyUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/396707spcred/396707normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:39 AM175Summary396707United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings reflect Walgreen Co.'s leading position in an industry with good business characteristics, as well as management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales and units. Prescriptions, which comprise 64% of Walgreen's revenue, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Deerfield, Ill.-based Walgreen operates more than 4,414 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to post double-digitUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/382814spcred/382814normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:37 AM175Summary382814United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCommercial MBSCorporationsHealth CareRetailSummaryThe ratings on Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales and units. Prescriptions, which comprise 64% of Walgreen's revenue, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Deerfield, Ill.-based Walgreen operates more than 4,414 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to postUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCMBSCORPHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/368833spcred/368833normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:32 AM175Summary368833United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSHealth CareRetailSummaryThe ratings on Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales and units. Prescriptions, which comprise 64% of Walgreen's revenue, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Deerfield, Ill.-based Walgreen operates more than 4,336 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to postUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSHealthRetailCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/361289spcred/361289normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:31 AM175Summary361289United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Walgreen Co. reflect the company's leading position in an industry with good business characteristics and management's commitment to maintaining financial strength. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales and units. Prescriptions, which comprise 64% of Walgreen's revenue, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Deerfield, Ill.-based Walgreen operates more than 4,291 drug stores in 44 states and Puerto Rico. Walgreen has demonstrated unparalleled consistency in operating performance within the sector. The company continues to postUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/350072spcred/350072normThe latest Summary from S&Pglobalstructured7/19/2008 2:43:30 AM175Summary350072United StatesDrug RetailUnited StatesGlobal IssuersStructured FinanceCorporationsCommercial MBSRetailHealth CareSummaryThe ratings on Walgreen Co. (Walgreen) reflect the company's leading position in an industry with good business characteristics and the belief that management is committed to maintaining financial strength. Walgreen operates more than 4,227 stores in 44 states and Puerto Rico, making it the largest drug retailer in the U.S. based on store count. The company commands a leading position in most of its major markets and is the largest chain drugstore in the industry, based on sales. Prescriptions, which comprise 62% of Walgreen's revenue, continue to drive growth and should do so well into the future due to an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. Walgreen has demonstratedUSA93142M93142J93142K93142293142E93142L30101010 301010 3010 30Walgreen Co.102515USAWAGSUMMARYGLOBISSSTRUCCORPCMBSRetailHealthCredit & Investment ResearchS&P Credit Research